More on GILD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $143.44 |
|
|||
| Open | $145.10 | ||||
| 52 Wk High | $108.63 | ||||
| 52 Wk Low | $71.39 | ||||
| Day High | $148.97 | ||||
| Day Low | $144.30 | ||||
| P/E | 81.55 | ||||
| EPS | $1.81 | ||||
| Volume | 6,738,793 | ||||
- Form 4 GILEAD SCIENCES, INC. For: Aug 17 Filed by: Dickinson Andrew D
- Form 4 GILEAD SCIENCES, INC. For: Aug 17 Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Dickinson Andrew D
- Form 4 GILEAD SCIENCES, INC. For: Aug 10 Filed by: Cain Wettan Keeley M
- Morgan Stanley tracks US drug market prescriptions for week ending July 31
- Form S-3ASR GILEAD SCIENCES, INC.
- Form 10-Q GILEAD SCIENCES, INC. For: Jun 30
- Gilead Sciences (GILD) PT Raised to $123 at RBC Capital
- CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results
Entities mentioned with GILD
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Options | View Related Stories »
- Show More...
